Valuation: GlaxoSmithKline plc

Market Cap 74.29B 100B 86.78B 82.06B 139B 9,610B 140B 979B 377B 4,873B 376B 368B 15,540B P/E 2026 *
14.2x
P/E 2027 * 11.8x
Enterprise Value 94.97B 128B 111B 105B 178B 12,285B 180B 1,252B 482B 6,229B 481B 470B 19,866B EV / Sales 2026 *
2.8x
EV / Sales 2027 * 2.6x
Free-Float
92.75%
Yield 2026 *
3.75%
Yield 2027 * 4.04%
Manager TitleAgeSince
Chief Executive Officer 52 01/01/2026
Director of Finance/CFO 64 01/05/2023
Compliance Officer - 01/08/2018
Director TitleAgeSince
Director/Board Member 52 06/05/2026
Director/Board Member 64 01/01/2018
Chairman 67 01/09/2019
Change 5-day change 1-year change 3-year change Capi.($)
-0.19%+1.09%+51.85%+97.36% 1,013B
+0.33%-0.71%+50.62%+65.50% 644B
+0.49%+5.73%+20.88%+72.92% 465B
+0.51%+3.94%+39.86%+40.10% 352B
+1.25%+2.97%+18.68%+24.95% 264B
+0.84%+4.69%+7.50%+13.69% 253B
-1.53%-4.46%+36.90%+44.08% 203B
+0.39%-4.26%-22.97%-57.47% 188B
-0.08%-0.23%+30.00%+93.34% 181B
Average +0.38%-1.08%+25.92%+43.83% 395.97B
Weighted average by Cap. +0.23%+0.01%+34.87%+60.02%

Financials

2026 *2027 *
Net sales 33.93B 45.76B 39.64B 37.48B 63.69B 4,390B 64.17B 447B 172B 2,226B 172B 168B 7,098B 35.5B 47.88B 41.47B 39.22B 66.63B 4,593B 67.14B 468B 180B 2,329B 180B 176B 7,427B
Net income 5.35B 7.21B 6.25B 5.91B 10.04B 692B 10.11B 70.49B 27.12B 351B 27.09B 26.49B 1,119B 6.28B 8.47B 7.34B 6.94B 11.79B 813B 11.88B 82.83B 31.87B 412B 31.83B 31.13B 1,315B
Net Debt 20.68B 27.89B 24.16B 22.84B 38.81B 2,675B 39.11B 273B 105B 1,357B 105B 102B 4,326B 17.97B 24.23B 20.99B 19.85B 33.72B 2,324B 33.98B 237B 91.12B 1,179B 91.02B 89B 3,759B
Logo GlaxoSmithKline plc
GSK plc is the world's No. 2 pharmaceutical group. Net sales break down by family of products as follows: - pharmaceutical products (41.3%): intended mainly for HIV infection (57% of net sales), immune system disorders and respiratory diseases (28.3%), and cancer (14.7%); - OTC and parapharmaceutical medicine (30.7%); - vaccines (28%). Net sales are distributed geographically as follows: the United Kingdom (2.1%), Europe (21%), the United States (51.6%), and other (25.3%).
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
-
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!